Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin L Robb

Showing results (1-10 of 358) with videos related to

Pageof 36
Sort By:
Idrugs : the Investigational Drugs Journal|December 15, 2010
HIV vaccine development: past, present and futureMerlin L Robb
Lancet (London, England)|November 18, 2008
Failure of the Merck HIV vaccine: an uncertain step forwardMerlin L Robb
Journal of the International AIDS Society|November 23, 2014
The transient HIV remission in the Mississippi baby: why is this good news?Jintanat Ananworanich, Merlin L Robb
Current Opinion in HIV and AIDS|October 8, 2016
Lessons from acute HIV infectionMerlin L Robb, Jintanat Ananworanich
Ebiomedicine|May 18, 2019
Harnessing circulating microRNAs for early HIV diagnosisSandhya Vasan, Merlin L Robb
Ebiomedicine|April 22, 2017
Accessories to SIV Control: T Cell Vaccination Shows PotentialMerlin L Robb, Diane L Bolton
The Lancet. Infectious Diseases|February 15, 2014
Shot in the HAART: vaccine therapy for HIVMerlin L Robb, Jerome H Kim
The Lancet. HIV|September 24, 2016
The doctor's dilemma and vaccine therapy for HIVTrevor A Crowell, Merlin L Robb
The Lancet. Infectious Diseases|February 25, 2014
Phambili: moving forward without the blindfoldNelson L Michael, Merlin L Robb
Current Opinion in HIV and AIDS|February 21, 2015
Broadly neutralizing antibody and the HIV reservoir in acute HIV infection: a strategy toward HIV remission?Jintanat Ananworanich, Brian McSteen, Merlin L Robb
Pageof 36

Showing results (1-10 of 358) with videos related to

Sort By:
Pageof 36
Idrugs : the Investigational Drugs Journal|December 15, 2010
HIV vaccine development: past, present and futureMerlin L Robb
Lancet (London, England)|November 18, 2008
Failure of the Merck HIV vaccine: an uncertain step forwardMerlin L Robb
Journal of the International AIDS Society|November 23, 2014
The transient HIV remission in the Mississippi baby: why is this good news?Jintanat Ananworanich, Merlin L Robb
Current Opinion in HIV and AIDS|October 8, 2016
Lessons from acute HIV infectionMerlin L Robb, Jintanat Ananworanich
Ebiomedicine|May 18, 2019
Harnessing circulating microRNAs for early HIV diagnosisSandhya Vasan, Merlin L Robb
Ebiomedicine|April 22, 2017
Accessories to SIV Control: T Cell Vaccination Shows PotentialMerlin L Robb, Diane L Bolton
The Lancet. Infectious Diseases|February 15, 2014
Shot in the HAART: vaccine therapy for HIVMerlin L Robb, Jerome H Kim
The Lancet. HIV|September 24, 2016
The doctor's dilemma and vaccine therapy for HIVTrevor A Crowell, Merlin L Robb
The Lancet. Infectious Diseases|February 25, 2014
Phambili: moving forward without the blindfoldNelson L Michael, Merlin L Robb
Current Opinion in HIV and AIDS|February 21, 2015
Broadly neutralizing antibody and the HIV reservoir in acute HIV infection: a strategy toward HIV remission?Jintanat Ananworanich, Brian McSteen, Merlin L Robb
Pageof 36